CUMYL-PINACA
| CUMYL-PINACA | |
|---|---|
| CUMYL-PINACA.png | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 1400742-14-7 |
| PubChem | 118796952 |
| DrugBank | |
| ChemSpider | 29762284 |
| KEGG | |
CUMYL-PINACA is a synthetic cannabinoid that has been used as an active ingredient in synthetic cannabis products. It is a potent agonist of the CB1 receptor and CB2 receptor, which are part of the endocannabinoid system.
Chemical Structure and Properties[edit]
CUMYL-PINACA is chemically classified as an indazole-based synthetic cannabinoid. Its full chemical name is 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide. The compound has a molecular formula of C22H25N3O and a molecular weight of 347.46 g/mol.
Pharmacology[edit]
CUMYL-PINACA acts as a potent agonist at the CB1 receptor and CB2 receptor, which are part of the endocannabinoid system. These receptors are involved in a variety of physiological processes including pain sensation, appetite, and mood. The activation of these receptors by CUMYL-PINACA can lead to effects similar to those produced by tetrahydrocannabinol (THC), the primary psychoactive component of cannabis.
Legal Status[edit]
CUMYL-PINACA is classified as a Schedule I substance under the Controlled Substances Act in the United States, indicating that it is considered to have a high potential for abuse and no accepted medical use. In the United Kingdom, it is classified as a Class B drug under the Misuse of Drugs Act 1971. In Canada, it is listed under Schedule II of the Controlled Drugs and Substances Act.
Health Risks and Toxicity[edit]
The use of synthetic cannabinoids like CUMYL-PINACA has been associated with a range of adverse health effects, including tachycardia, hypertension, nausea, vomiting, hallucinations, and seizures. Due to its potency and the variability in the composition of synthetic cannabis products, the risk of overdose and severe toxicity is significant.
See Also[edit]
-
CUMYL-PINACA
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
